Modeling Parkinson's disease genetics: Altered function of the dopamine system in Adh4 knockout mice

Behavioural Brain Research

Volumn 217, Issue 2, 2011, Pages 439-445

  Belin, Andrea Carmine ^a   Westerlund, Marie ^a   Anvret, Anna ^a   Lindqvist, Eva ^a   Pernold, Karin ^a   Ögren, Sven Ove ^a   Duester, Gregg ^b   Galter, Dagmar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Alcohol; Aldehyde; Amphetamine; Apomorphine; Genetics; Locomotion

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALCOHOL DEHYDROGENASE; ALCOHOL DEHYDROGENASE 4; APOMORPHINE; DEXAMPHETAMINE; DOPAMINE; MONOAMINE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FRONTAL CORTEX; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SMELLING; SUBSTANTIA NIGRA; WILD TYPE;

3,4-DIHYDROXYPHENYLACETIC ACID; ALCOHOL DEHYDROGENASE; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; HOMOVANILLIC ACID; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOREPINEPHRINE; ODORS; PARKINSON DISEASE; SEROTONIN; SMELL;

EID: 78650415859     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.11.023     Document Type: Article

References (39)

1. Andersson H., Luthman J., Lindqvist E., Olson L. Time-course of trimethyltin effects on the monoaminergic systems of the rat brain. Neurotoxicology 1995, 16:201-210.
2. Beyer P.L., Palarino M.Y., Michalek D., Busenbark K., Koller W.C. Weight change and body composition in patients with Parkinson's disease. J Am Diet Assoc 1995, 95:979-983.
3. Boleda M.D., Saubi N., Farres J., Pares X. Physiological substrates for rat alcohol dehydrogenase classes: aldehydes of lipid peroxidation, omega-hydroxyfatty acids, and retinoids. Arch Biochem Biophys 1993, 307:85-90.
4. Braak H., Del T.K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
5. S. Buervenich, Thesis: candidate genes and the dopamine system - possible implications in complex neurological and psychiatric disease. Karolinska Institutet, Stockholm, Sweden, 2002.
6. Buervenich S., Sydow O., Carmine A., Zhang Z., Anvret M., Olson L. Alcohol dehydrogenase alleles in Parkinson's disease. Mov Disord 2000, 15:813-818.
7. Deltour L., Foglio M.H., Duester G. Impaired retinol utilization in Adh4 alcohol dehydrogenase mutant mice. Dev Genet 1999, 25:1-10.
8. Deltour L., Foglio M.H., Duester G. Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and metabolism of retinol to retinoic acid. J Biol Chem 1999, 274:16796-16801.
9. Deltour L., Haselbeck R.J., Ang H.L., Duester G. Localization of class I and class IV alcohol dehydrogenases in mouse testis and epididymis: potential retinol dehydrogenases for endogenous retinoic acid synthesis. Biol Reprod 1997, 56:102-109.
10. Duester G., Farres J., Felder M.R., Holmes R.S., Hoog J.O., Pares X., et al. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochem Pharmacol 1999, 58:389-395.
11. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
12. Falck B., Hillarp NÅ, Thieme G., Torp A. Fluorescence of catecholamines and related compounds condensed with formaldehyde. J Histochem Cytochem 1962, 10:348-354.
13. Fleming S.M., Tetreault N.A., Mulligan C.K., Hutson C.B., Masliah E., Chesselet M.F. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 2008, 28:247-256.
14. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, Inc., San Diego.
15. Haehner A., Boesveldt S., Berendse H.W., Mackay-Sim A., Fleischmann J., Silburn P.A., et al. Prevalence of smell loss in Parkinson's disease - A multicenter study. Parkinsonism Relat Disord 2009.
16. Haselbeck R.J., Ang H.L., Duester G. Class IV alcohol/retinol dehydrogenase localization in epidermal basal layer: potential site of retinoic acid synthesis during skin development. Dev Dyn 1997, 208:447-453.
17. Haselbeck R.J., Duester G. Regional restriction of alcohol/retinol dehydrogenases along the mouse gastrointestinal epithelium. Alcohol Clin Exp Res 1997, 21:1484-1490.
18. Haselbeck R.J., Hoffmann I., Duester G. Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways. Dev Genet 1999, 25:353-364.
19. Hurd Y.L., Ungerstedt U. Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur J Pharmacol 1989, 166:261-269.
20. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 1998, 18:1979-1986.
21. Marcellino D., Lindqvist E., Schneider M., Muller C.E., Fuxe K., Olson L., et al. Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice. Neurobiol Dis 2010, 40:460-466.
22. Niwa T., Maruyama W., Nakahara D., Takeda N., Yoshizumi H., Tatematsu A., et al. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry. J Chromatogr 1992, 578:109-115.
23. Ögren S.O. The behavioral pharmacology of typical and antipsychotic drugs. The handbook of experimental pharmacology 1996, 224-244. Springer Verlag, Berlin. J.G. Csernansky (Ed.).
24. Ögren S.O., Hall H., Köhler C., Magnusson O., Sjöstrand S.E. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology (Berl) 1986, 90:287-294.
25. Ögren S.O., Ross S.B. Substituted amphetamine derivatives II. Behavioural effects in mice related to monoaminergic neurones. Acta Pharmacol Toxicol (Copenh) 1977, 41:353-368.
26. Parkinson J. An essay on the shaking palsy 1817, Neely & Jones, London, Sherwood.
27. Reed D.R., Lawler M.P., Tordoff M.G. Reduced body weight is a common effect of gene knockout in mice. BMC Genet 2008, 9:4.
28. Selley M.L. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med 1998, 25:169-174.
29. Szalai G., Duester G., Friedman R., Jia H., Lin S., Roe B.A., et al. Organization of six functional mouse alcohol dehydrogenase genes on two overlapping bacterial artificial chromosomes. Eur J Biochem 2002, 269:224-232.
30. Taylor T.N., Caudle W.M., Shepherd K.R., Noorian A., Jackson C.R., Iuvone P.M., et al. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci 2009, 29:8103-8113.
31. Tietjen T.G., Mjaatvedt C.H., Yang V.W. Cellular localization of the class I alcohol dehydrogenase transcript in adult rat tissues. Histochem J 1994, 26:526-532.
32. Vaglenova J., Martinez S.E., Porte S., Duester G., Farres J., Pares X. Expression, localization and potential physiological significance of alcohol dehydrogenase in the gastrointestinal tract. Eur J Biochem 2003, 270:2652-2662.
33. Westerlund M., Belin A.C., Felder M.R., Olson L., Galter D. High and complementary expression patterns of alcohol and aldehyde dehydrogenases in the gastrointestinal tract. FEBS J 2007, 274:1212-1223.
34. Westerlund M., Galter D., Carmine A., Olson L. Tissue- and species-specific expression patterns of class I, III, and IV Adh and Aldh 1 mRNAs in rodent embryos. Cell Tissue Res 2005, 322:227-236.
35. Yamanaka Y., Walsh M.J., Davis V.E., Salsolinol an alkaloid derivative of dopamine formed in vitro during alcohol metabolism. Nature 1970, 227:1143-1144.
36. Yokoyama H., Baraona E., Lieber C.S. Molecular cloning and chromosomal localization of the ADH7 gene encoding human class IV (sigma) ADH. Genomics 1996, 31:243-245.
37. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996, 93:2696-2701.
38. Zetterström R.H., Lindqvist E., Mata dU, Tomac A., Eriksson U., Perlmann T., et al. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 1999, 11:407-416.
39. Zetterström R.H., Simon A., Giacobini M.M., Eriksson U., Olson L. Localization of cellular retinoid-binding proteins suggests specific roles for retinoids in the adult central nervous system. Neuroscience 1994, 62:899-918.